A complete solution
that enables efficient and cost-effective
detection and reporting of AF and other
Assured Data Clarity
The Zensor™ Device, is the only 3-lead, 14 day continuous ECG and Wi-Fi enabled event monitor available on the market. This small yet powerful system enables the detection and reporting of common arrhythmias including Atrial Fibrillation. Reliable beat-by-beat disclosure data can be directly downloaded and used to generate timesaving reports ready for analysis and consultation. The Zensor™ device is a reusable system that is cost-effective with assured data clarity.
Beat by Beat
- Full diagnostic quality three-lead remote ECG for enhanced cardiac visualisation
- Continuous recording, monitoring and data capture for up to 14 days
- Wi-Fi enabled event transmission
- Electrodes designed to minimise motion artefacts for improved data clarity
- User-friendly and comfortable to wear encouraging high patient compliance
- Direct access to full diagnostic ECG and event data reports
Simplified and Streamlined Workflow
for quicker diagnosis
Zensor™ device assigned, placed on patient and activated
Optional Wi-Fi enabled event notification
End-of-monitoring full data upload direct to Zensor+ Software
High-quality full disclosure ECG data and summary report
Enhanced diagnosis through assured data clarity
Nearly half of all arrhythmias go undetected within the 24 hours of continuous monitoring provided to patients in routine clinical practice1. Reliable, high quality data captured through 14 day data recording can capture up to 100% of arrhythmias1 .
Efficient and streamlined workflow
The simplicity of a single device incorporating both ambulatory ECG and event monitoring can help in streamlining the day-to-day workflow. Patient data can be directly uploaded to pre-set and customisable templates to produce time-saving and comprehensive reports, ready for consultation.
Cost-effective AF detection
As a reusable system, the Zensor™ device is associated with substantial savings compared to single-patient use devices. With the combined device and software package, mainstream AF detection becomes increasingly cost-effective with each subsequent use.
Maximum patient compliance
The Zensor™ device is user-friendly and the patented electrodes are comfortable to wear and can be self-applied allowing for higher patient compliance.
LifeSignals and Renew Health
LifeSignals Inc announces merger of LifeSignals portfolio with the connected health portfolio of Renew Health Limited to form LifeSignals Group Inc Li...
Join us at the Heart Rhythm Congress in Birmingham.
We are delighted to be participating in the Heart Rhythm Congress at the ICC in Birmingham. We will be joining over 3,000 delegates attending a packed...